Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Atea, Athersys, Azurrx, Bavarian Nordic, Biontech, Daiichi Sankyo, Gigagen, I-Mab, Immvira, Innovation, Innovent, Lynk, Nrx, Opthea, Pfizer, Sinovac, Valneva.